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In this paper, we develop a non-local mathematical model describing cancer cell inva-
sion and movement as a result of integrin-controlled cell–cell adhesion and cell–matrix
adhesion, and transforming growth factor-beta (TGF-β) eﬀect on cell proliferation and
adhesion, for two cancer cell populations with diﬀerent levels of mutation. The model
consists of partial integro-diﬀerential equations describing the dynamics of two cancer
cell populations, coupled with ordinary diﬀerential equations describing the extracellu-
lar matrix (ECM) degradation and the production and decay of integrins, and with a
parabolic PDE governing the evolution of TGF-β concentration. We prove the global
This is an Open Access article published by World Scientiﬁc Publishing Company. It is distributed
under the terms of the Creative Commons Attribution 4.0 (CC-BY) License. Further distribution
of this work is permitted, provided the original work is properly cited.
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existence of weak solutions to the model. We then use our model to explore numerically
the role of TGF-β in cell aggregation and movement.
Keywords: Non-local model of cancer progression; existence; boundedness of solution;
cell heterogeneity; TGF-β; cell–cell and cell–matrix adhesion.
AMS Subject Classiﬁcation: 35A01, 35Q92, 35R09, 92C15, 92C17, 92-08
1. Introduction
Cellular adhesion, i.e. cell–cell and cell–matrix adhesion, and cellular proliferation
are fundamental features of multicellular organisms, linked to maintenance of order
in the organisms, e.g. tissue formation, stability and breakdown.3 These inter-
actions between cells and the extracellular matrix (ECM) are mediated through
cell surface receptors, a major group of which is represented by the integrins,68
and various cytokines and chemokines. Another group of molecules involved in
cell–cell adhesion is represented by the cadherin families.26 There are several sig-
nalling pathways that control normal cell processes like cell proliferation, divi-
sion, cellular adhesion and apoptosis, with transforming growth factor β (TGF-β)
pathway to be one of the most critical. Belonging to a large family of multifunctional
polypeptides, TGF-β regulates the proliferation, diﬀerentiation, adhesion, migra-
tion and apoptosis of many cell types, including endothelial cells, hematopoietic
cells and lymphocytes,47 and ECM production.31
Various signals, including integrin, Notch, Wnt, TNF-a, and EGF signals, have
been reported to cooperate or synergize with TGF-β signalling and stimulate
tumour invasion and metastasis.47 Experimental studies44 showed that the loss of
TGF-β responsiveness is one of the events that initiate ﬁbrotic disease and malig-
nant progression of cancer, as well as cancer metastasis.65 TGF-β induces morpho-
logical, biochemical and transcriptional changes towards a mesenchymal phenotype,
a process called epithelial to mesenchymal transition (EMT) (see Refs. 42 and 51
and many references therein). EMT occurs when epithelial cells lose their epithe-
lial cell characteristics and become mesenchymal. Mesenchymal cells can return to
an epithelial phenotype, a process called mesenchymal-epithelial transition (MET).
Through these processes, cancer cells become metastatic and form new colonies at
distant sites.
Experimental studies33,41 have shown that tumours consist of heterogeneous
populations of cells, which are the result of genetic instability. Intra-tumour het-
erogeneity appears in almost all phenotypic cell features: from cell morphology, to
gene expression, motility, proliferation, immunogenicity and metastatic potential.45
While both normal cells and cancer cells appear to be heterogeneous for various
characteristics (e.g. surface antigens), cellular heterogeneity is shown54 to be more
pronounced in malignant neoplasms. Experimental studies have shown complex
interactions between clonal cancer cell sub-populations in heterogeneous tumours:
from stable coexistence to competitive exclusion.38 The metastatic and invasive
potential of heterogeneous tumours is inﬂuenced by the interactions among the
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The multiple roles of TGF-β pathway on tumour 3
cells, and the interactions between cells and ECM components. To detach from the
main aggregation/tissue, cells loose cell–cell adhesion and strengthen cell–matrix
adhesion (these changes in cell–cell/cell–ECM adhesion can be inﬂuenced by TGF-
β signalling), which leads to ECM remodelling and degradation (with the help of
enzymes called matrix metalloproteinases; MMPs).
Over the last three decades there have been multiple mathematical models intro-
duced to investigate the formation and movement of various cell aggregations (see,
for example, Refs. 1, 3, 5, 6, 8, 48, 49, 55, 56 and 59, and the many references
therein). While there are mathematical models in the literature that investigate
the roles of TGF-β on cancer dynamics, generally these models focus on particular
aspects of cancer progression (e.g. growth46,63). There are very few models that
investigate, in an integrated manner, the multiple roles of TGF-β on cancer evo-
lution (see, for example Refs. 4 and 67), and in general these models focus on the
motility and growth rate of early stage cancer cells.
In this study, we present a novel mathematical model which investigates in a
integrated manner the various roles of TGF-β on tumour growth/decay, and on cell–
cell and cell–matrix interactions, but paying particular attention to the opposite
role of TGF-β on early stage versus late stage cancer cells. To this end, we intro-
duce a non-local hyperbolic–parabolic model for cell–cell and cell–matrix adhesion
for two cancer cell populations: an early stage cancer population, moving both ran-
domly and in a directed manner in response to cell–cell and cell–matrix adhesive
forces, and a late stage cancer population (i.e. a mutated clone) moving only in a
directed manner following self-adhesive and cross-adhesive cell–cell forces, as well as
matrix interactions. Since TGF-β does not aﬀect only tumour growth, but impacts
also cell adhesion,4 we model the interactions between TGF-β and integrins that
inﬂuence the cell–cell and cell–matrix adhesive forces. The computational results
show a range of heterogeneous invasion patterns, as a result of the opposite role of
TGF-β in early and late stages of cancer. Analytical results show the global exis-
tence of bounded solutions (hence existence of various types of invasion patterns).
We note that existence results have been shown for local nonlinear parabolic PDEs
for cell movement coupled with ODEs describing the ECM dynamics with tissue
remodelling,22,32,61,62 as well as for non-local parabolic models describing cancer
invasion when the ECM production is zero10 and when it is nonzero.60 Existence
results have also been shown for local hyperbolic models for chemo-sensitive move-
ment.29 However, in contrast to these previous results, here we show existence for
a non-local parabolic–hyperbolic model for cancer cell movement.
The structure of this paper is as follows. In Sec. 2, we present our mathematical
model, which consists of partial integro-diﬀerential equations describing the dyna-
mics of cell populations in early and late stages of cancer, coupled with ordinary dif-
ferential equations describing ECM and integrins dynamics, and a parabolic partial
diﬀerential equation describing TGF-β dynamics. In Sec. 3, we present a suitable
notion of weak solution to the model and we prove the global-in-time existence
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4 V. Bitsouni, M. A. J. Chaplain & R. Eftimie
of bounded solutions to our system as the vanishing viscosity limit of a classical
solution to an associated parabolic problem. In Sec. 4, we undertake numerical sim-
ulations to investigate the eﬀect of TGF-β on cancer cell movement, and observe a
range of patterns obtained for diﬀerent values of parameters of the model. Finally,
in Sec. 5, we summarise our results and give some concluding remarks.
2. The Mathematical Model of TGF-β Regulatory
Network in Cancer
TGF-β plays a crucial role in embryonic development, wound healing and cancer.
Moreover, TGF-β signalling stimulates EMT in certain epithelial cells (see Ref. 51
and many references therein) and consequently induces various diseases, including
cancer. The way that TGF-β interacts with cancer cells varies between early and
late stages of cancer (see Fig. 1), making its behaviour diﬃcult to analyse. We
consider a two-population model describing the behaviour of an early stage cancer
population and a late stage cancer (descendant clone) population, which interact
with each other, as well as with the ECM, via long-range integrin-controlled adhe-
sive and repulsive forces18,23 on bounded spatial domain Ω ⊂ Rn with smooth
boundary ∂Ω. For T > 0 let ΩT = (0, T )× Ω. Denote by u1(t, x) and u2(t, x) the
density of early and late stage cancer cells, respectively, at position x and time t,
by f(t, x) the ECM density, and by c(t, x) the density of integrin receptors on the
surface of cancer cells (receptors involved in cell–cell and cell–matrix interactions).
Finally, we denote by b(t, x) the TGF-β concentration. For compact notation, we
deﬁne the vectors u(t, x) = (u1(t, x), u2(t, x)) and υ(t, x) = (u(t, x), f(t, x)).
EMT
Late stages cancer cells
Apoptotic bodies
−Apoptosis
Healthy cells or early stage cancer cells
Loss of cell−cell adhesion
Metastasis
−Tumour promoter−Regulator of cellular adhesion and proliferation
−EMT inducer−Tumour suppressor
−
TGF β−
TGF β
Fig. 1. A caricature summarising the dual role of TGF-β in cancer progression.
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The multiple roles of TGF-β pathway on tumour 5
Cancer cells dynamics. Cancer cells can switch from a homogeneous type of
invasion to a heterogeneous type of invasion described by (directionally moving)
invading chains.12 Therefore, we assume that the movement of the early stage
cancer cell population u1 is governed by random motility (which underlines a homo-
geneous type of invasion), as well as directed motility in response to cell–cell and
cell–matrix adhesive forces (which underlines the heterogeneous type of invasion).9
Let Du describe the random motility coeﬃcient and F1[u, f, c, b] describe the non-
local directed motility. In contrast, the late stage cancer cell population, u2, moves
only in a directed manner (hence exhibiting a heterogeneous type of invasion) in
response to cell–cell and cell–matrix adhesion forces (described by a non-local term
F2[u, f, c, b]). Moreover, the u1 cells can mutate into u2 cells at a constant rate M .
TGF-β has been found to have bidirectional functions in the progression of cancer.
In early stages of cancer, TGF-β is an antiproliferative and proapoptotic signal,
while in late stages of cancer it acts as a tumour promoter.57 Thus, we have the
following equations describing the dynamics of the two cancer cell populations:
∂u1
∂t
= Du∆u1 −∇ · (u1F1[u, f, c, b])−Mu1 + G1(u, b), (2.1a)
∂u2
∂t
= −∇ · (u2F2[u, f, c, b]) +Mu1 + G2(u, b). (2.1b)
Taking into account the eﬀect of TGF-β on cancer cell proliferation and assum-
ing that both u1 and u2 cells can proliferate in a logistic manner (to describe the
observed slow-down in tumour growth following the loss of nutrients37), we choose
the growth functions to be given by
Gi(u, b) = riui
(
1− u1 + u2
ku
)(
1 + (−1)icb b
bm
)
, i = 1, 2, (2.2)
where r1 and r2 are the growth rates of the u1 and u2 populations, respectively, ku
is the carrying capacity, bm is the maximum TGF-β concentration, and cb is a coeﬃ-
cient related to the eﬀect of TGF-β on cancer cell proliferation/decay. In particular,
the term (−1)i models the anti-tumour eﬀect of TGF-β on early tumours (i = 1),
and the pro-tumour eﬀect on late tumours (i = 2). Note that these growth func-
tions incorporate also the principle of competition between clonal sub-populations
in heterogeneous tumours.38
The non-local cell–cell and cell–matrix adhesion and repulsion forces for can-
cer cell populations u1 and u2, are described by a function that depends on cell
densities, ECM and integrin densities, and concentrations of TGF-β molecules
Fi : C(Ω¯ : R)5 → C1,ζ(Ω¯ : Rn), ζ ∈ (0, 1], i = 1, 2, (2.3)
given by the following relation
Fi[u, f, c, b](x) :=
∫
Ω
K(|y − x|)gi(u(y), f(y), c(x), b(x))dy, i = 1, 2, (2.4)
where K ∈ L∞(Ω), with ∂xK ∈ L∞(Ω). The functions gi(u, f, c, b), i = 1, 2, describe
the nature of the cell–cell and cell–matrix adhesive forces. These functions increase
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6 V. Bitsouni, M. A. J. Chaplain & R. Eftimie
when the cell density and ECM density increase, and accordingly they decrease
when the cell density and ECM density decrease. The functions gi, i = 1, 2, are
given by
gi(u, f, c, b) := Si(c, b)ui + S(c, b)uj + Ci(c, b)f, i, j = 1, 2, i = j, (2.5)
where Si(c, b) is the cell–cell self-adhesion strength function for populations ui,
S(c, b) is the cell–cell cross-adhesion strength function between the two populations,
and Ci(c, b) is the adhesion strength function between population ui and ECM.
Integrins are molecules known to have a regulative role in cell–cell and cell–
matrix adhesion,4 while the role of TGF-β in cellular adhesion is dual: (i) Promotes
cell–matrix adhesion by inducing the synthesis and the secretion of ECM–adhesion
molecules laminin and ﬁbronectin and the upregulation of integrin expression for
these matrix-adhesion molecules30,66; (ii) Decreases cell–cell adhesion.52,67 Thus,
to deﬁne these adhesion strength functions we consider the integrin density, c,
and TGF-β concentration, b. Since cell mutation could lead to more integrins,35
we consider strength functions with diﬀerent integrin levels for each of the two
populations. The more integrins a cell has, the stronger its adhesion force. Therefore,
biologically realistic choices for these adhesion strength functions are the increasing,
bounded and positive functions given by:
Si(c, b) = si∗(1 + tanh(aic− abib)), S(c, b) = s∗(1 + tanh(dc− dbb)),
Ci(c, b) = ci∗(1 + tanh(eic + ebib)), i = 1, 2,
(2.6)
where ai, abi , d, db, ei, ebi and si∗, s∗, ci∗, i = 1, 2, are positive real numbers.
ECM dynamics. The ECM is considered as non-motile matter, with changes to
its density due to degradation by u1 and u2 cell populations upon contact at rates
α > 0 and β > 0, respectively, and ECM density remodelling back to normal
levels, at a constant rate of δ > 0. Moreover, TGF-β induces the synthesis of ECM
adhesion molecules,66,67 at a rate of θβ > 0. Thus the dynamics of ECM, f(t, x), is
described by:
∂f
∂t
= −αu1f − βu2f + θβbf + δf
(
1− f
fm
)
, (2.7)
where fm is the maximum ECM density at which the ECM ﬁlls up all available
physical space.
Integrin dynamics. We assume that the level of integrins depends on cancer cell
density, such that cell mutation changes the density of receptors (since in highly
metastatic cancers, the expression of integrins is up-regulated35). Moreover, TGF-β
signalling up-regulates the integrin expression,4,42 at a rate of p3. Therefore, the
dynamics of integrins, c(t, x), can be described by:
∂c
∂t
= p1u1 + p2u2 + p3bc− qc, (2.8)
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The multiple roles of TGF-β pathway on tumour 7
where q is the decay rate of c, and p1 and p2 are the production rates of integrins by
u1 and u2 cancer cell populations, respectively. To model the increase in receptors
on highly mutated cancer cells, we assume that p2 > p1 (see Table A.2).
TGF-β dynamics. Finally, TGF-β is assumed to diﬀuse freely in the spatial
domain, after being released by u1 and u2 cells, and decay at a rate of qb > 0.
Therefore, the dynamics of TGF-β, b(t, x), is described by:
∂b
∂t
= Db∆b + λ(u)− qbb, (2.9)
where Db is the TGF-β diﬀusion coeﬃcient and λ(u) is the TGF-β production
term. Here, we choose λ(u) = µ1u1 + µ2u2, with µ1 and µ2 to be the production
rates of TGF-β by u1 and u2, respectively.
The relations (2.1)–(2.9) are summarised in the following system:
∂u1
∂t
= Du∆u1 −∇ · (u1F1[u, f, c, b])−Mu1 + G1(u, b), (2.10a)
∂u2
∂t
= −∇ · (u2F2[u, f, c, b]) + Mu1 + G2(u, b), (2.10b)
∂f
∂t
= −αu1f − βu2f + θβbf + δf
(
1− f
fm
)
, (2.10c)
∂c
∂t
= p1u1 + p2u2 + p3bc− qc, (2.10d)
∂b
∂t
= Db∆b + µ1u1 + µ2u2 − qbb. (2.10e)
We impose the following initial conditions:
ui(0, x) = ui0(x) ≥ 0, i = 1, 2, f(0, x) = f0(x) ≥ 0,
c(0, x) = c0(x) ≥ 0, b(0, x) = b0(x) ≥ 0, in Ω.
(2.11)
Finally, we assume that there is no-ﬂux of both cancer cells and TGF-β proteins
on the boundary of the domain,
〈∇ui, ν〉 = 0 = 〈∇b, ν〉, i = 1, 2, on (0,∞)× ∂Ω (2.12)
and
〈Fi[u, f, c, b], ν〉 = 0, i = 1, 2, on (0,∞)× ∂Ω, (2.13)
where ν is the outward unit normal vector to ∂Ω.
3. Existence of Solution
To prove the existence of solution for system (2.10), we use the theory of semi-
groups combined with the vanishing viscosity method (to transform Eq. (2.10b)
into a parabolic equation). Then we show that in the vanishing viscosity limit, we
obtain weak solutions for (2.10). We note that the steps in this proof of existence
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8 V. Bitsouni, M. A. J. Chaplain & R. Eftimie
of approximate solution follow similar approaches taken in Ref. 10, where a sim-
pler parabolic-ODE model with no production term in the ODE (i.e. the ODE in
Ref. 10 contains only decay term, which implies global boundedness of its solution)
is considered, whereas in our model the production terms in (2.10c)–(2.10d) add an
extra layer of complexity to the proof. Moreover, for the proof of vanishing viscosity
limit we use techiques similar to those in Ref. 29 for a hyperbolic–elliptic model.
The link between these two proofs is based on the extraction of the appropriate
estimates for the vanishing viscosity limit, for our more complex system of non-local
parabolic–hyperbolic equations coupled with ODEs.
3.1. Existence of approximate solution
We will approximate system (2.10) by the following system:
∂u1
∂t
−Du∆u1 + Mu1 = −∇u1 · F1[u1, u2, f , c, b]
− u1(∇ · F1[u1, u2, f , c, b]) + G1(u1, u2, b), (3.1a)
∂u2
∂t
− 
∆u2 + u2 = −∇u2 · F2[u1, u2, f , c, b]
− u2(∇ · F2[u1, u2, f , c, b]) + h1(u1, u2, b), (3.1b)
∂f 
∂t
= h2(u1, u

2, b
)f  − δ
fm
f 
2
, (3.1c)
∂c
∂t
= h3(u1, u

2) + c
h4(b), (3.1d)
∂b
∂t
−Db∆b + qbb = h5(u1, u2), (3.1e)
for 0 < 
 ≤ 1, where
h1(u1, u

2, b
) = Mu1 + u

2 + G2(u

1, u

2, b
),
h2(u1, u

2, b
) = −αu1 − βu2 + θβb + δ,
h3(u1, u

2) = p1u

1 + p2u

2, h4(b
) = p3b − q and
h5(u1, u

2) = µ1u

1 + µ2u

2.
(3.2)
The ICs are given by
ui(0, x) = ui0(x) ≥ 0, i = 1, 2, f (0, x) = f0(x) ≥ 0,
c(0, x) = c0(x) ≥ 0, b(0, x) = b0(x) ≥ 0, in Ω.
(3.3)
Finally, the BCs corresponding to (2.12)–(2.13) are given by the relations
〈∇ui , ν〉 = 0 = 〈∇b, ν〉, i = 1, 2, on (0,∞)× ∂Ω (3.4)
and
〈Fi[u1, u2, f , c, b], ν〉 = 0, i = 1, 2, on (0,∞)× ∂Ω. (3.5)
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The multiple roles of TGF-β pathway on tumour 9
For the full non-local interaction terms (2.3)–(2.4) we make the following
assumptions:
Fi[u1, u2, f, c, b](x) =
∫
Ω
Ni(x, y, u1(y), u2(y), f(y), c(x), b(x))dy, (3.6)
where Ni : Ω2 × R5 → Rn, i = 1, 2, is a continuous function, which satisﬁes
Ni(x, y, 0, c, b) = 0, i = 1, 2, for all (x, y) ∈ Ω2, c, b ∈ R, (3.7)
and
Ni(·, y, φ, χ, ψ, c, b) ∈ C1,ζ(Ω¯ : Rn), i = 1, 2, for all y ∈ Ω, (φ, χ, ψ) ∈ R3.
(3.8)
Since functions Si(c, b), S(c, b), Ci(c, b), i = 1, 2, (given by (2.6)) are bounded, we
assume that there is a constant LN , which depends on the bound for Si, S, Ci, i =
1, 2, such that for any φ1, φ2, χ1, χ2, ψ1, ψ2 ∈ R we have
|Ni(x, y, φ1, χ1, ψ1, c, b)−Ni(x, y, φ2, χ2, ψ2, c, b)|
+ |∂xNi(x, y, φ1, χ1, ψ1, c, b)− ∂xNi(x, y, φ2, χ2, ψ2, c, b)|
≤ LN (|φ1 − φ2|+ |χ1 − χ2|+ |ψ1 − ψ2|), i = 1, 2, (3.9)
uniformly with respect to (x, y) ∈ Ω2.
We assume that h′2, h′3 and h′4 exist, and that
h′2 : R× R× R → R, h′3 : R× R → R and h′4 : R → R (3.10)
are locally Lipschitz functions.
Based on relation (2.2) we can assume that there are constants Bi, Di > 0, i =
1, 2, such that for u1, u2, b ≥ 0, i = 1, 2, we have
Gi(u1, u

2, b
) ≤ Bi −Diui , i = 1, 2. (3.11)
Moreover, based on relation (3.2) we can assume that there are constants Λj >
0, j = 1, . . . , 4, such that for u1, u

2, f
, c, b ≥ 0:
f h2(u1, u

2, b
)− δ
fm
f 
2 ≤ Λ1b − Λ2f  (3.12)
and
ch4(b) ≤ Λ3b − Λ4c. (3.13)
We now consider the sectorial operators
A1 = −Du∆ +MI , A2 = −
∆+ I and A3 = −Db∆ + qbI (3.14)
in the space X = Lp(Ω), with common domain of deﬁnition
D = D(A1) = D(A2) = D(A3) =
{
w ∈ W 2,p : ∂w
∂ν
= 0 on ∂Ω
}
, (3.15)
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and Re(σ(Aj)) > 0, j = 1, 2, 3. Then the fractional powers are well deﬁned
Xγ = D(Aγ1 ) = D(A
γ
2 ) = D(A
γ
3 ), 0 < γ < 1, (3.16)
with the graph norm
‖x‖Xγ = ‖Aγj x‖X , for x ∈ Xγ, j = 1, 2, 3. (3.17)
Then from Ref. 27, we have the following embeddings:
Xγ ⊂ W 1,p(Ω) for γ > 1
2
, (3.18)
Xγ ⊂ C0,r(Ω¯) for r
2
+
n
2p
< γ <
1
2
+
n
2p
, 0 < r < 1, (3.19)
where C0,r(Ω¯) is the space of all Ho¨lder continuous functions with exponent r in
Ω. Notice that for
γ ∈
(
1
2
,
1
2
+
1
2p
)
for p > n, (3.20)
(3.18) and (3.19) are satisﬁed.
Moreover, since A1, A2 and A3 are sectorial operators, then each of −A1,−A2
and −A3 is the inﬁnitesimal generator of an analytic semigroup {e−tAj}t≥0, j =
1, 2, 3. Therefore, there exists a positive constant Cγ such that the following inequa-
lity holds27:
‖Aγj e−Ajtw‖X ≤ Cγt−γe−ξjt‖w‖X , for w ∈ X, (3.21)
where 0 < ξj < Re(σ(Aj)), j = 1, 2, 3, and
‖Aγj e−Ajtw‖X ≤ kγ‖w‖Xγ , for w ∈ Xγ , (3.22)
where kγ positive constant.
Theorem 3.1. Let u1(0, x), u

2(0, x), b
(0, x) ∈ Xγ and f (0, x), c(0, x) ∈ W 1,p
(Ω). If assumptions (3.3)–(3.13) and (3.20) are satisfied, then for any T > 0
there exists a unique global-in-time solution (u1, u

2, f
, c, b) ∈ C([0, T ); [Xγ]2 ×
[W 1,p(Ω)]2 × Xγ) to (3.1)–(3.5), which remains bounded and the bounds are

-independent. Moreover, the solution satisfies
(u1, u

2, b
) ∈ C1((0, T ); [Xγ]3) ∩ C((0, T ); [W 2,p(Ω)]3), (3.23)
f , c ∈ C1((0, T );W 1,p(Ω)). (3.24)
Proof. We will prove the existence of a local-in-time solution using the Banach
contraction theorem. We ﬁrst focus on the ODEs (3.1c) and (3.1d). We notice
that relation (3.18) implies that u1, u

2, b
 ∈ W 1,p(Ω), and since the functions h2 :
R × R × R → R, h3 : R × R → R and h4 : R → R are locally Lipschitz, we have
by the property of superposition operator that the value of the functions h2, h3
and h4 is also in W 1,p(Ω).58 The space W 1,p(Ω) for p > n is an algebra with
pointwise multiplication, and thus it follows that the functions (u1, u

2, f
, b) →
P1 = h2(u1, u

2, b
)f  − δfm f 
2
and (u1, u

2, c
, b) → P2 = h3(u1, u2) + ch4(b) are
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The multiple roles of TGF-β pathway on tumour 11
also W 1,p-valued. Since the right-hand side functions of Eqs. (3.1c) and (3.1d) are
locally Lipschitz, it follows from assumption (3.10) and embeddings (3.18)–(3.19)
that the mapping P : (W 1,p(Ω))5 → (W 1,p(Ω))2, P = (P1, P2), is a locally Lipschitz
function.
For a ﬁxed T > 0 we note that functions:
t → f0 +
∫ t
0
P1(u1(s), u

2(s), f
(s), b(s))ds, (3.25)
t → c0 +
∫ t
0
P2(u1(s), u

2(s), c
(s), b(s))ds, (3.26)
belong to the space C([0, T ];W 1,p(Ω)).
Then, the system of the PDEs (3.1a), (3.1b) and (3.1e) with (3.3) can be
rewritten as:
zt = Az + H(z), in ΩT ,
z(0, x) = z0(x), in Ω, (3.27)
with
z =


u1
u2
b

, A =


A1 0 0
0 A1 0
0 0 A3

,
and
H(z) =


−∇u1 · F1[u1, u2, f , c, b]− u1(∇ · F1[u1, u2, f , c, b]) + G1(z)
−∇u2 · F2[u1, u2, f , c, b]− u2(∇ · F2[u1, u2, f , c, b]) + h1(z)
h5(u1, u

2)

,
or, equivalently, we write that A = A1 ×A2 ×A3 is sectorial in X ×X ×X , where
(A1 × A2 × A3)(u1, u2, b) = (A1u1, A2u2, A3b),27 and the mapping H : (Xγ)3 →
(X)3, H = (H1, H2, H3) is deﬁned as the mapping of the right-hand side of
Eqs. (3.1a), (3.1b) and (3.1e). Using similar arguments as before for P , and assump-
tion (3.9) we deduce that H : (Xγ)3 → (X)3 is locally Lipschitz continuous.
Let us now denote Y = X ×X ×W 1,p(Ω) ×W 1,p(Ω) ×X . For a ﬁxed T > 0,
we deﬁne the space
Y γT = C([0, T ];Y
γ), (3.28)
where Y γ = Xγ×Xγ×W 1,p(Ω)×W 1,p(Ω)×Xγ equipped with the norm ‖y‖Y γ =
max{‖y1‖Xγ , ‖y2‖Xγ , ‖y3‖W 1,p(Ω), ‖y4‖W 1,p(Ω), ‖y5‖Xγ}, for y=(y1, y2, y3, y4, y5) ∈
Y γ .
We deﬁne the mapping J : Y γT → Y γT with J = (J1, J2, J3, J4, J5) given by the
following relation
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J =


J1 = e−A1tu10 +
∫ t
0
e−A1(t−s)H1(u1(s), u

2(s), f
(s), c(s), b(s))ds,
J2 = e−A2tu20 +
∫ t
0
e−A2(t−s)H2(u1(s), u

2(s), f
(s), c(s), b(s))ds,
J3 = f0 +
∫ t
0
P1(u1(s), u

2(s), f
(s), b(s))ds,
J4 = c0 +
∫ t
0
P2(u1(s), u

2(s), c
(s), b(s))ds,
J5 = e−A3tb0 +
∫ t
0
e−A3(t−s)H3(u1(s), u

2(s))ds.
(3.29)
Let R > 0 be such that max{‖u10‖Xγ , ‖u20‖Xγ , ‖b0‖Xγ} < R/(2kγ), where kγ
satisﬁes relation (3.22), and max{‖f0‖W 1,p(Ω), ‖c0‖W 1,p(Ω)} < R/2 for (u10 , u20 ,
f0, c0, b0) ∈ Y γ . We deﬁne the ball
BR = {y ∈ Y γT : ‖y‖Y γT ≤ R} ⊂ Y
γ
T . (3.30)
Thus, there exists MR > 0 such that supy∈BR ‖(H1, H2, P1, P2, H3)(y)‖Y < MR.
We show that J maps BR into itself and that J is a strict contraction. By using
relations (3.21)–(3.22) and (3.29) we obtain, for T small enough,
‖J1[u1, u2, f , c, b](t)‖Xγ ≤ kγ‖u10‖Xγ + MR
∫ T
0
Cγ(t− s)−γe−ξ1(t−s)ds
≤ R
2
+ MR
Cγ
1− γ T
1−γ . (3.31)
Similarly we obtain
‖J2[u1, u2, f , c, b](t)‖Xγ ≤
R
2
+ MR
Cγ
1− γ T
1−γ (3.32)
and
‖J5[u1, u2](t)‖Xγ ≤
R
2
+ MR
Cγ
1− γ T
1−γ . (3.33)
Moreover, for J3 and J4 we have
‖Jl[u1, u2, f , c, b](t)‖W 1,p(Ω) ≤
R
2
+ MRT, l = 3, 4. (3.34)
Hence, we can choose T suﬃciently small such that {MR Cγ1−γT 1−γ ,MRT } < R2 , to
assert that J(BR) ⊂ BR. We note also that J [u1, u2, f , c, b] is continuous from
[0, T ] to Eγ , as it can be easily proved using inequality (3.22). Thus J maps BR
into itself.
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The multiple roles of TGF-β pathway on tumour 13
If y1, y2 ∈ BR then for t ∈ [0, T ] we have
‖J1[y1](t) − J1[y2](t)‖Xγ ≤
∫ t
0
‖Aγ1e−ξ1(t−s)‖X‖H1(y1(s))−H1(y2(s))‖Xds
≤ CγLR
∫ T
0
(t− s)−γeξ1(t− s)‖y1 − y2‖Y γT ,
where LR is the Lipschitz constant of H . Similar estimates can be obtained for the
diﬀerences of the rest of the arguments. Therefore, it follows that
‖J [y1]− J [y2]‖Y γT ≤
1
2
‖y1 − y2‖Y γT for all y1, y2 ∈ BR. (3.35)
Hence for T small enough J is a contraction mapping. Therefore, by Banach
ﬁxed point theorem, J has a unique ﬁxed point in BR. Moreover, functions
f , c : [0, T ] → C(Ω) are locally Lipschitz, thus f , c ∈ W 1,∞([0, T ];W 1,p(Ω))
(see Theorem 4, Sec. 5.8.2 in Ref. 21). Therefore, it follows from Sec. 3.3 in Ref. 27
that there is a maximal time of existence Tmax of regular solution (u1, u

2, b
) ∈
C([0, Tmax); (Xγ)3) such that for t ∈ (0, Tmax) we have (u1, u2, b) ∈ D(A).
Then, from Ref. 27 (Sec. 3.3 and Theorem 3.5.2 in Sec. 3.5) we obtain that
(u1, u

2, b
) ∈ Cζ((0, Tmax); (Xβ)3) for some ζ, β ∈ (0, 1). Hence (3.1a), (3.1b) and
(3.1e) are satisﬁed in a pointwise manner on (0, Tmax)×Ω. It follows now from rela-
tions (3.8) and (3.19), and the regularity theory of parabolic systems, that u1, u

2
and b are classical solutions of (3.1a), (3.1b) and (3.1e), respectively.
Let us now prove the uniqueness of solution. Let y1 = (u11, u12, f1, c1, b1) and y2 =
(u21, u22, f2, c2, b2) be two solutions of system (3.1), with the same initial conditions.
By linearity y = y1− y2 is a solution of (3.1) with zero initial conditions. Then, since
all nonlinear terms are Lipschitz continuous and the components of the solution are
L∞-bounded functions on bounded time intervals, we have
d
dt
‖y‖2L2(Ω) ≤ k0‖y‖2L2(Ω), for t ∈ [0, Tmax), y(0) = 0, (3.36)
for a constant k0, and since ‖y(0)‖L2(Ω) = 0, Gronwall’s inequality implies that
‖y(t)‖L2(Ω) = 0 for all t ≥ 0, so y = 0.
The equation for the ECM density given by (3.1c) does not involve any spa-
tial derivatives and x behaves as a parameter. Thus, it is an ordinary diﬀerential
equation in which the right-hand side is zero when f (t, x) = 0 and for which local
Lipschitz conditions hold. Therefore, from Picard–Lindelo¨f theorem we obtain a
local unique solution for the initial value problem (3.1c), with f (0, x) = 0. In the
same way, we obtain a local unique solution for the initial value problem (3.1c),
with f (0, x) ≥ 0. Therefore, since f (0, x) ≥ 0, from uniqueness of solutions we
have f (t, x) ≥ 0 for all t > 0, x ∈ Ω. Then from maximum principle arguments it
follows from system (3.27) that u1, u

2, b
 ≥ 0 on [0, Tmax)× Ω.
Finally, the equation for the integrin density given by (3.1d) can be treated in a
similar manner as Eq. (3.1c) for the ECM density. Again we have an ordinary dif-
ferential equation in which the right-hand side is greater than or equal to zero when
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c(t, x) = 0, and for which local Lipschitz conditions hold. Therefore, c(t, x) ≥ 0
on [0, Tmax)× Ω.
We proceed now with the proof of global-in-time solution. Let us ﬁrst integrate
Eq. (3.1a) on Ω. Then, from the boundary conditions (3.4)–(3.5) and relation (3.11)
we obtain
d
dt
∫
Ω
u1(t, x)dx ≤ B1|Ω| − (M + D1)
∫
Ω
u1(t, x)dx. (3.37)
Thus, Gronwall’s inequality yields the estimate
sup
t∈[0,Tmax)
‖u1(t, ·)‖L1(Ω) ≤ max
{
B1|Ω|
M + D1
, ‖u10‖L1(Ω)
}
:= Mu1 . (3.38)
Similarly, we have
sup
t∈[0,Tmax)
‖u2(t, ·)‖L1(Ω) ≤ max
{
MMu1 + B2|Ω|
D2
, ‖u20‖L1(Ω)
}
:= Mu2 (3.39)
and
sup
t∈[0,Tmax)
‖b(t, ·)‖L1(Ω) ≤ max
{
µ1Mu1 + µ2Mu2
qb
, ‖b0‖L1(Ω)
}
:= Mb, (3.40)
hence from relations (3.12)–(3.13) and Gronwall’s inequality again we have
sup
t∈[0,Tmax)
‖f (t, ·)‖L1(Ω) ≤ max
{
Λ1Mb
Λ2
, ‖f0‖L1(Ω)
}
:= Mf (3.41)
and
sup
t∈[0,Tmax)
‖c(t, ·)‖L1(Ω) ≤ max
{
p1Mu1 + p2Mu2 + Λ3Mb
Λ4
, ‖c0‖L1(Ω)
}
:= Mc.
(3.42)
Thus, from relations (3.6)–(3.9) we have for all t ∈ [0, Tmax):∥∥∥∥∥∥

 n∑
j=1
∂xjFi[u

1, u

2, f
, c, b]

+ Fi[u1, u2, f , c, b]
∥∥∥∥∥∥
L∞(Ω)
≤ LN (‖u1(t)‖L1(Ω)
+ ‖u2(t)‖L1(Ω) + ‖f (t)‖L1(Ω)) ≤ LN(Mu1 + Mu2 + Mf ), i = 1, 2. (3.43)
From system (3.27), we rewrite the elliptic operators in the form:
−Du∆u1 +
n∑
j=1
bj1∂xju

1 + d1u

1,
−
∆u2 +
n∑
j=1
bj2∂xju

2 + d2u

2,
−Db∆b + qbb,
where we denote by bji = Fij [u

1, u

2, f
, c, b] and by di =
∑n
j=1 ∂xjFi[u

1, u

2, f
,
c, b], i=1, 2, j = 1, . . . , n. From relation (3.43) it follows that bji and di, i = 1, 2, are
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bounded on (0,∞)×Ω. Hence, from the fact that the reaction terms are dissipative
(see Ref. 13), it follows by Mo¨ser–Alikakos method (see Sec. 9.3 in Ref. 13) that the
uniform in time L1(Ω) estimate implies the uniform in time L∞(Ω) estimate for
the solution (u1, u

2, b
) of (3.27). Therefore, there is a constant M∞ independent
of 
 (see Remark 3.1), such that
sup
t∈[0,Tmax)
(‖u1(t)‖L∞(Ω) + ‖u2(t)‖L∞(Ω) + ‖b(t)‖L∞(Ω)) < M∞. (3.44)
Moreover, from (3.12)–(3.13) and (3.44), and the comparison theorem it follows
that
sup
t∈[0,Tmax)
‖f (t)‖L∞(Ω) < max
{
‖f0‖L∞(Ω), Λ1M∞Λ2
}
, (3.45)
and
sup
t∈[0,Tmax)
‖c(t)‖L∞(Ω) < max
{
‖c0‖L∞(Ω), (p1 + p2)M∞, Λ3M∞Λ4
}
. (3.46)
Relations (3.44)–(3.46) can be used to show that
‖Hi(u1(s), u2(s), f (s), c(s), b(s))‖X ≤ Mγi(1 + ‖ui(t)‖Xγ ) for t ∈ [0, Tmax)
(3.47)
and
‖H3(u1(s), u2(s))‖X ≤ Mγ3 for t ∈ [0, Tmax), (3.48)
where Mγi ,Mγ3 , i = 1, 2, are constants depending on M∞.
We show now the global existence of solution by contradiction. Let us suppose
that for Tmax < ∞ we have
sup
t∈[0,Tmax)
(‖u1(t)‖Xγ + ‖u2(t)‖Xγ + ‖f (t)‖W 1,p(Ω) + ‖c(t)‖W 1,p(Ω)
+ ‖b(t)‖Xγ) →∞ as t → Tmax. (3.49)
From relation (3.47) and Volterra-type integral inequality13 it follows, as in Corol-
lary 3.3.5 in Ref. 27, that
sup
t∈[0,Tmax)
‖ui(t)‖Xγ ≤
(
kγ
∥∥ui0∥∥Xγ + CγMγi
∫ Tmax
0
e−ξi(t−s)
(t− s)γ
)
CTmax ,
where CTmax := CCγMγi ,γ,Tmax , i = 1, 2, is a continuous function increasing with
respect to Tmax, while for the function b we have from relation (3.48) that
sup
t∈[0,Tmax)
‖b(t)‖Xγ ≤
(
kγ ‖b0‖Xγ + CγMγ3
∫ Tmax
0
e−ξ3(t−s)
(t− s)γ
)
.
Note that kγ and Cγ are 
-independent constants since 0 < 
 ≤ 1 (see Theorem 1.3.4
in Ref. 27). We conclude that
sup
t∈[0,Tmax)
(‖u1(t)‖Xγ + ‖u2(t)‖Xγ + ‖b(t)‖Xγ) < ∞. (3.50)
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Whence, by (3.18) it follows now that
sup
t∈[0,Tmax)
(‖u1(t)‖W 1,p(Ω) + ‖u2(t)‖W 1,p(Ω) + ‖b(t)‖W 1,p(Ω)) < ∞. (3.51)
By Eq. (3.1c) and direct calculations, we obtain
∇f t = (−α∇u1 − β∇u2 + θβ∇b)f  + h6∇f , (3.52)
where
h6 := h2 − 2δ
fm
f  = −αu1 − βu2 + θβb + δ −
2δ
fm
f  ≤ θβb + δ. (3.53)
For notational convenience, in what follows we denote various non-negative con-
stants, which are independent of T or t, by cj , j = 1, 2, . . . , 8.
Multiplying (3.52) by p∇f |∇f |p−2, using (3.53), Young’s inequality, and the
estimates (3.44), (3.45) and (3.51), and integrating over Ω, we deduce that
d
dt
‖∇f ‖pLp(Ω) ≤ p
∫
Ω
(−α∇u1 − β∇u2 + θβ∇b)f ∇f |∇f |p−2dx
+ pθβ
∫
Ω
b|∇f |pdx + pδ‖∇f ‖pLp(Ω)
≤ pmax{α, β, θβ}‖f ‖L∞(Ω)
(∫
Ω
|∇u1||∇f |p−1dx
+
∫
Ω
|∇u2||∇f |p−1dx +
∫
Ω
|∇b||∇f |p−1dx
)
+ p(θβ‖b‖L∞(Ω) + δ)‖∇f ‖pLp(Ω)
≤ c1(‖∇u1‖pLp(Ω) + ‖∇u2‖pLp(Ω) + ‖∇b‖pLp(Ω)) + c2‖∇f ‖pLp(Ω).
By Gronwall’s inequality and previous estimates, we have
sup
t∈[0,Tmax)
‖f (t)‖W 1,p(Ω) ≤ c3ec4t, for t ≥ 0. (3.54)
Similarly, by Eq. (3.1d) and direct calculations, we obtain
∇ct = p1∇u1 + p2∇u2 + p3∇bc + p3b∇c − q∇c. (3.55)
Multiplying now (3.55) by p∇c|∇c|p−2, using the estimates (3.44), (3.46) and
(3.51), as well as Young’s inequality, and integrating over Ω, we obtain
d
dt
‖∇c‖pLp(Ω) ≤ pp1
∫
Ω
∇u1∇c|∇c|p−2dx + pp2
∫
Ω
∇u2∇c|∇c|p−2dx
+ pp3
∫
Ω
∇bc∇c|∇c|p−2dx + pp3
∫
Ω
b|∇c|pdx− pq
∫
Ω
|∇c|pdx
≤ pmax{p1, p2, p3‖c‖L∞(Ω)}
(∫
Ω
|∇u1||∇c|p−1dx
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+
∫
Ω
|∇u2||∇c|p−1dx +
∫
Ω
|∇b||∇c|p−1dx
)
+ p(p3‖b‖L∞(Ω) − q)‖∇c‖pLp(Ω)
≤ c5(‖∇u1‖pLp(Ω) + ‖∇u2‖pLp(Ω) + ‖∇b‖pLp(Ω)) + c6‖∇c‖pLp(Ω).
This, together with Gronwall’s inequality and previous estimates, yields
sup
t∈[0,Tmax)
‖c(t)‖W 1,p(Ω) ≤ c7ec8t, for t ≥ 0. (3.56)
Bounds (3.50), (3.54) and (3.56) contradict (3.49), therefore the solution exists
globally.
Remark 3.1. It is easy to see how the proof of Mo¨ser–Alikakos method in Ref. 13
can be used in our case to show the 
-independent L∞-estimates given in relation
(3.44). Following along the same lines with the proof of Lemma 9.3.1 in Ref. 13,
we obtain a constant c′ (as described in relation (9.3.11) of the proof in Ref. 13)
such that
c′ := max{const. a0, 1, D|Ω|,K2}, (3.57)
where a0 will be each of the diﬀusion coeﬃcients Du, 
 and Db. Using the fact that
0 < Du, 
,Db ≤ 1 it follows that c′ is 
-independent.
By this result, it follows that the rest of the estimates given by relations (3.45)–
(3.48), (3.50)–(3.51), (3.54) and (3.56) are 
-independent.
3.2. Vanishing viscosity limit
Now we are ready to take the vanishing viscosity limit 
 → 0 and prove the existence
of solution for system (2.10). First we introduce the notion of a weak solution to
problem (2.10)–(2.11) with (2.12)–(2.13).
Definition 3.1. A function (u1, u2, f, c, b) ∈ L∞(Ω¯T )∩L∞(0, T ; [L1(Ω)]5) is called
a weak solution of the problem (2.10)–(2.11) with (2.12)–(2.13) if:
(i) For all φ ∈ C∞0 (ΩT ) we have
−
∫
Ω¯T
u1φt −Du∇u1 · ∇φ + u1F1[u, f, c, b] · ∇φ
=
∫
Ω¯T
[−Mu1 + G1(u, b)]φ, (3.58)
−
∫
Ω¯T
u2φt + u2F2[u, f, c, b] · ∇φ =
∫
Ω¯T
[Mu1 + G2(u, b)]φ, (3.59)
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−
∫
Ω¯T
fφt =
∫
Ω¯T
[
−αu1f − βu2f + θβbf + δf
(
1− f
fm
)]
φ, (3.60)
−
∫
Ω¯T
cφt =
∫
Ω¯T
[p1u1 + p2u2 + p3bc− qc]φ, (3.61)
−
∫
Ω¯T
bφt −Db∇b · ∇φ =
∫
Ω¯T
[µ1u1 + µ2u2 − qbb]φ. (3.62)
(ii) The functions u1, u2, f, c and b satisfy the initial conditions u10(x), u20(x),
f0(x), c0(x) and b0(x), respectively, given by (2.11), in the weak sense,
i.e. there exists a set E ⊂ [0, T ] of Lebesgue measure zero such that
u1(t0, ·), u2(t0, ·), f(t0, ·), c(t0, ·) and b(t0, ·) are deﬁned almost everywhere in
Ω for t0 ∈ [0, T ]\E and satisfy:
lim
t0→0,t0∈[0,T ]\E
∫
Ω
|ui(t0, x)− ui0(x)|dx = 0, i = 1, 2, (3.63)
lim
t0→0,t0∈[0,T ]\E
∫
Ω
|f(t0, x)− f0(x)|dx = 0, (3.64)
lim
t0→0,t0∈[0,T ]\E
∫
Ω
|c(t0, x)− c0(x)|dx = 0, (3.65)
lim
t0→0,t0∈[0,T ]\E
∫
Ω
|b(t0, x)− b0(x)|dx = 0. (3.66)
We show now the L1-estimates with respect to time, which will be used in the
proof of existence of solution to model (2.10).
Theorem 3.2. Let the assumptions of Theorem 3.24 hold. Then for each ρ >
0 there exist nondecreasing functions ωuiρ , ω
f
ρ , ω
c
ρ, ω
b
ρ ∈ C([0,∞)) with ωuiρ (0) =
ωfρ (0)=ωcρ(0)=ωbρ(0) = 0, i = 1, 2, such that for any 
 ∈ (0, 1] and for any t,
t + ∆t ∈ [0, T ], ∆t ≥ 0 we have for a ball Bρ = {|x| ≤ ρ} that :∫
Bρ
|ui(t + ∆t, x)− ui(t, x)|dx ≤ ωuiρ (∆t), i = 1, 2, (3.67)
∫
Bρ
|f (t + ∆t, x)− f (t, x)|dx ≤ ωfρ (∆t), (3.68)
∫
Bρ
|c(t + ∆t, x)− c(t, x)|dx ≤ ωcρ(∆t), (3.69)
∫
Bρ
|b(t + ∆t, x)− b(t, x)|dx ≤ ωbρ(∆t). (3.70)
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Proof. Let us consider a function g ∈ C20 (Ω) with supp(g) ⊂ Bρ. Then from the
estimates obtained by Theorem 3.24 we have∣∣∣∣
∫
Ω
(u2(t + ∆t, x)− u2(t, x))g(x)dx
∣∣∣∣
=
∣∣∣∣∣
∫
Ω
g(x)
∫ t+∆t
t
u2t(s, x)dsdx
∣∣∣∣∣ ≤
∣∣∣∣∣
∫ t+∆t
t
∫
Ω

u2(s, x)∆g(x)dxds
∣∣∣∣∣
+
∣∣∣∣∣
∫ t+∆t
t
∫
Ω
u2(s, x)F2[u

1, u

2, f
, c, b]∇g(x)dxds
∣∣∣∣∣
+
∣∣∣∣∣
∫ t+∆t
t
∫
Ω
[Mu1(s, x) + G2(u

1, u

2, b
)]g(x)dxds
∣∣∣∣∣
≤ C(ρ,M∞)∆t ‖g‖C2(Ω) .
Similarly we can obtain estimates for u1, f, c and b. Then, as in Ref. 29, the
L1-estimates of u1, u2, f , c and b with respect to time t follow.
Theorem 3.3. Let ui(0, x), b(0, x) ∈ Xγ, i = 1, 2, and f(0, x), c(0, x) ∈ W 1,p(Ω).
If assumptions of Theorem 3.24 are satisfied, then there exists a weak solution
(u1, u2, f, c, b) of model (2.10) with (2.11)–(2.13), such that for all T > 0 the weak
solution satisfies for almost all (t, x) ∈ Ω¯T
0 ≤ u1(t, x), u2(t, x), f(t, x), c(t, x), b(t, x) ≤ C(M∞). (3.71)
Proof. By Theorem 3.24, we have that for all 0 < 
 ≤ 1 and T > 0 there exists
a classical solution (u1, u

2, f
, c, b) of problem (3.1)–(3.3), which is uniformly
bounded in L∞(Ω¯T ). From estimates (3.51), (3.54) and (3.56) it follows that
sup
t∈[0,T )
(‖u1(t)‖W 1,1(Ω) + ‖u2(t)‖W 1,1(Ω) + ‖f (t)‖W 1,1(Ω)
+ ‖c(t)‖W 1,1(Ω) + ‖b(t)‖W 1,1(Ω)) < C. (3.72)
We consider for m ∈ N a sequence 
m with 
m → 0 for m →∞. Then by estimate
(3.72) and L1-estimates with respect to time, obtained from Theorem 3.2, it follows
by Fre´chet–Kolmogorov theorem that the sequences {um1 , um2 , f m , cm , bm} are
precompact in L1loc(Ω¯T ). Using a standard diagonal extraction argument we obtain
subsequences, denoted also as {um1 , um2 , f m , cm , bm}, and functions u1, u2, f , c,
b ∈ L1loc(Ω¯T ) with umi → ui, i = 1, 2, f m → f , cm → c and bm → b in L1loc(Ω¯T ).
This implies that the convergence is even pointwise a.e. for a suitable subsequence.
From uniform L1-bounds of {um1 (t, ·), um2 (t, ·), f m(t, ·), cm(t, ·), bm(t, ·)} we have
that u1(t, ·), u2(t, ·), f(t, ·), c(t, ·), b(t, ·) ∈ L1(Ω). Multiplying now Eqs. (2.10a)–
(2.10e) with a test function φ ∈ C∞0 (ΩT ), taking the integral and integrating by
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parts over Ω¯T yields
−
∫
Ω¯T
um1 φt + Duu
m
1 ·∆φ + um1 F1[um , f m , cm , bm ] · ∇φ
=
∫
Ω¯T
[−Mum1 + G1(um , bm)]φ, (3.73)
−
∫
Ω¯T
um2 φt + u
m
2 F2[u
m , f m , cm , bm ] · ∇φ
=
∫
Ω¯T
[Mum1 + G2(u
m , bm)]φ + 

∫
Ω¯T
um2 ∆φ, (3.74)
−
∫
Ω¯T
f mφt =
∫
Ω¯T
[−αum1 f m − βum2 f m
+ θβbmf m + δf m(1 − f m/fm)]φ, (3.75)
−
∫
Ω¯T
cmφt =
∫
Ω¯T
[p1um1 + p2u
m
2 + p3b
mcm − qcm ]φ, (3.76)
−
∫
Ω¯T
bmφt + Dbbm ·∆φ =
∫
Ω¯T
[µ1um1 + µ2u
m
2 − qbbm ]φ. (3.77)
The last term in (3.74) vanishes in the limit due to the uniform L∞-bound on
{um2 } and from the pointwise convergence the Lebesgue’s dominated convergence
theorem ensures that the limit (u1, u2, f, c, b) satisﬁes (3.58)–(3.62). Moreover,
(u1, u2, f, c, b) ∈ L∞(Ω¯T ), and by relations (3.44)–(3.46) and Remark 3.1 we obtain
the bounds (3.71).
It remains to show the initial conditions (3.63)–(3.66). Let us ﬁrst deﬁne the set
E ⊂ [0, T ] such that for all t0 ∈ [0, T ]\E we have for almost all x ∈ Ω that (t0, x)
is Lebesgue point of u1, u2, f, c and b. The set E has Lebesgue measure zero. For
any ﬁxed t0 ∈ [0, T ]\E and ρ > 0 it follows from Theorem 3.2 that∫
Bρ
|ui(t0, x)− ui0(x)|dx ≤
∫
Bρ
|ui(t0, x)− umi (t0, x)|dx + ωuiρ (t0), i = 1, 2.
The pointwise convergence of {umi }, i = 1, 2, yields∫
Bρ
|ui(t0, x)− ui0(x)|dx ≤ ωuiρ (t0), i = 1, 2.
The properties of ωuiρ (t0), i = 1, 2, give (3.63) since ui has compact support. Simi-
larly we obtain relations (3.64)–(3.66).
4. Numerical Results
4.1. Non-dimensionalisation of the model
In this section, we investigate numerically the type of patterns exhibited by model
(2.10) in the one-dimensional case. Let Rs > 0 be the cells sensing radius (i.e. the
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maximum range over which cells can detect other surrounding cells). We consider
a bounded domain Ω = [0, Rs], and following the approach in Ref. 24, we choose
the non-local terms Fi[u, f, c, b], i = 1, 2, to be given by
Fi[u, f, c, b](t, x) :=
1
Rs
∫ Rs
0
1∑
k=0
η(k)K(r)gi(υ(t, x + rη(k)), c(t, x), b(t, x))dr,
(4.1)
where η(k) = (−1)k, k = 0, 1 and gi, i = 1, 2, as described in Sec. 2 (see relation
(2.5)).
Let us deﬁne the kernel K, assuming that it is attractive at medium/long ranges
(i.e. at the edges of the cell) and repulsive at very short ranges (i.e. over cell surface),
and thus can be deﬁned as
K(x) := qaKa(x)− qrKr(x), (4.2)
with qa and qr describing the magnitudes of attractive and repulsive interactions,
respectively, and Ka(x) and Kr(x) describe the spatial ranges over which these
interactions take place. We consider translated Gaussian attraction and repulsion
kernels (as in Ref. 20):
K(x) =
qa√
2πm2a
e
− (x−sa)2
2m2a − qr√
2πm2r
e
− (x−sr)2
2m2r , (4.3)
where sa and sr represent half of the length of attraction and repulsion ranges,
respectively, with sr < sa. Also, mj = sj/8, j = a, r, represent the width of the
attractive and the repulsive interaction ranges.
To perform numerical simulations, we ﬁrst non-dimensionalise system (2.10) by
using the following quantities:
t˜ =
t
τ
, x˜ =
x
L0
, u˜i =
ui
ku
, f˜ =
f
fm
,
c˜ =
c
cm
, b˜ =
b
bm
, R˜s =
Rs
L0
, r˜ =
r
L0
,
S˜(c˜, b˜) =
τku
L20
S(cmc˜ + bmb˜), S˜i(c˜, b˜) =
τku
L20
Si(cmc˜ + bmb˜),
C˜i(c˜, b˜) =
τfm
L20
Ci(cmc˜ + bmb˜), i = 1, 2.
(4.4)
The length scale, L0, is in the range of 0.1–1 cm, and is deﬁned as the maximum
invasion distance of the cancer cells at the early stage of invasion.2 The time
scale is deﬁned as τ := L20/Dτ , where Dτ is the characteristic diﬀusion coeﬃ-
cient (∼10−6cm2s−1). Furthermore, we rescale the cancer cells, the ECM, the inte-
grins and the TGF-β with ku, fm, cm and bm, respectively. Here, ku is the carrying
capacity of the cancer cell populations and it is taken to be ∼6.7 · 107cell/volume,
and fm is the maximum ECM density at which the ECM ﬁlls up all available phys-
ical space and it is taken to be equal to 4mg/volume, as in Ref. 19. Finally, cm
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is the maximum integrin density and it is taken to be 5 · 104 integrins per cell (as
in Ref. 7), while bm is the maximum TGF-β concentration taken to be equal to
141.59ng/volume (as in Ref. 34).
We choose the dimensionless functions K˜(r˜) := L0K(L0r˜) = L0K(r) and
g˜i(u˜, f˜ , c˜, b˜) := (τ/L20)gi(u, f, c, b), i = 1, 2. Therefore, the non-local terms are given
by F˜i[u˜, f˜ , c˜, b˜] := (τ/L0)Fi[u, f, c, b], i = 1, 2.
Finally, we obtain the dimensionless parameters:
D˜u =
Du
Dτ
, D˜b =
Db
Dτ
, M˜ = τM, α˜ = ταku, β˜ = τβku,
θ˜β = τθβbm, δ˜ = τδ, p˜3 = τp3bm, q˜ = τq, q˜b = τqb,
r˜i = τri, p˜i =
τpiku
cm
and µ˜i =
τµiku
bm
, i = 1, 2.
(4.5)
After dropping the tildes for notational convenience, we obtain the following non-
dimensionalised system:
∂u1
∂t
= Du
∂2u1
∂x2
− ∂
∂x
(u1F1[u, f, c, b])
−Mu1 + r1u1(1− u1 − u2)(1 − cbb), (4.6a)
∂u2
∂t
= − ∂
∂x
(u2F2[u, f, c, b]) +Mu1 + r2u2(1− u1 − u2)(1 + cbb), (4.6b)
∂f
∂t
= −αu1f − βu2f + θβbf + δf(1− f), (4.6c)
∂c
∂t
= p1u1 + p2u2 + p3bc− qc, (4.6d)
∂b
∂t
= Db
∂2b
∂x2
+ µ1u1 + µ2u2 − qbb. (4.6e)
4.2. Pattern formation
To discretize our model we use a time-splitting approach. We use a Crank–Nicolson
scheme to propagate the solution of the diﬀusion term. Then, we use the Nessyahu–
Tadmor scheme53 for the time-propagation of the advection terms. Finally, for
the time-propagation of the reaction terms we use a fourth-order Runge–Kutta
algorithm, where the integrals are further discretised using the Simpson’s rule. All
simulations are performed on a domain of length L = 10 with periodic boundary
conditions (introduced to approximate the dynamics on an inﬁnite domain). For
this reason, the integrals are wrapped-up at the boundaries. The simulations ran
for times up to t = 1000, but for clarity in Figs. 2–5 we show mainly the dynamics
for t ≤ 400. If the patterns do not reach a steady state before t = 400, we add inset
ﬁgures showing the dynamics for t ≤ 1000.
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Fig. 2. (Colour online) Patterns exhibited by model (4.6) showing the eﬀect of TGF-β on cancer
cell density for cell–matrix adhesion greater than cell–cell adhesion, i.e. s∗1 = 1.8, s
∗
2 = 0.6, s
∗ =
1, c∗1 = 1.9 and c
∗
2 = 2.5. The rest of model parameters are given in Table A.2. (a), (b) Density
of u1 and u2 populations in the absence of TGF-β; (a′), (b′) Density of u1 and u2 populations in
the presence of TGF-β.
The initial conditions for the cancer cell populations are small random pertur-
bations of rectangular-shaped aggregations located in the middle of the domain
ui(0, x) =
{
uci + rand(0, 10
−4), x ∈ (L/2− 1, L/2 + 1),
0, everywhere else,
(4.7)
with uc1 = 0 and uc2 = 0.1. For the ECM density, f , we assume that the tumour has
already degraded some of its surrounding tissues:
f(0, x) = 1− 0.5u1(0, x)− 0.5u2(0, x). (4.8)
Finally, the integrin density and TGF-β concentration, c and b, respectively, are
proportional to the initial tumour cell density
c(0, x) = 0.5u1(0, x) + 0.5u2(0, x) (4.9)
and
b(0, x) = 0.05u1(0, x) + 0.05u2(0, x). (4.10)
To investigate the eﬀect of TGF-β signalling on cell proliferation, movement
and aggregation (the last two aspects being controlled by cell adhesion), we focus
on three possible cases for the magnitudes of cell–cell and cell–matrix adhesion.
For each of these three cases, we investigate the dynamics of u1 and u2 populations
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when TGF-β is absent and does not inﬂuence cell proliferation or cell adhesion (i.e.
for cb = abi = db = ebi = θβ = p3 = µ1 = µ2 = 0, i = 1, 2), and when TGF-β is
present and inﬂuences both cell proliferation and cell adhesion (i.e. for cb = 20 and
abi , db, ebi , θβ , p3, µ1, µ2, = 0, i = 1, 2).
(i) Cell–cell adhesion < cell–matrix adhesion. To investigate the eﬀect of greater
cell–matrix adhesion, we choose s∗1 = 1.8, s
∗
2 = 0.6, s
∗ = 1, c∗1 = 1.9 and
c∗2 = 2.5 and the rest of model parameters as given in Table A.2. We see in
Figs. 2(a) and 2(b) that in the absence of TGF-β, the population of early
stage cancer cells (u1) decreases, while the population of late stage cancer
cells (u2) increases and dominates the long-term dynamics. This behaviour
is expected due to the mutation term “−Mu1”, and due to large cell–matrix
adhesion, which impedes cells to move and thus leads to the formation of
stationary pulses for t > 50. Considering now the eﬀect of TGF-β, we see in
Figs. 2(a′) and 2(b′) that population u1 vanishes faster, due to the presence
of antiproliferative and proapoptotic signals from TGF-β (described by cb > 0
in Eq. (4.6a)). Population u2 persists and increases signiﬁcantly, due to the
promoting eﬀects of TGF-β on the late stages of cancer, which also induces
the movement of the cancer cells (via EMT) thus leading to their spread over
the domain until they reach the boundaries.
Fig. 3. (Colour online) Patterns exhibited by model (4.6) showing the eﬀect of TGF-β on cancer
cell density for cell–cell adhesion greater than cell–matrix adhesion, i.e. s∗1 = 2.4, s
∗ = 2.1, s∗2 =
2, c∗1 = 1.1 and c
∗
2 = 0.9. The rest of model parameters are given in Table A.2. (a), (b) Density
of u1 and u2 populations in the absence of TGF-β. The inset in panel (b) shows the long-term
dynamics of u2(t, x) (for t ≤ 1000); (a′), (b′) Density of u1 and u2 populations in the presence of
TGF-β.
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(ii) Cell–cell adhesion > cell–matrix adhesion. To investigate the eﬀect of greater
cell–cell adhesion, we choose s∗1 = 2.4, s
∗ = 2.1, s∗2 = 2, c
∗
1 = 1.1 and c
∗
2 = 0.9,
and the rest of model parameters as given in Table A.2. We see in Figs. 3(a)
and 3(b) that due to the weak cell–matrix adhesive forces, u1 and u2 cells start
to move through the domain in a collective manner. Figures 3(a) and 3(a′) show
that u1 population vanishes in the absence and in the presence of TGF-β (due
to the mutation term). We also note that the spread of u1 cells is reduced in the
presence of TGF-β, likely due to the positive eﬀect of TGF-β on cell–matrix
adhesion (see the term “+ebib” in Eqs. (2.6)). In Figs. 3(b) and 3(b′) we see
that the u2 population changes its movement from a chaotic-like dynamics
(in the absence of TGF-β; panel (b)) to a spread over the whole domain (in
the presence of TGF-β; panel (b′)), as a result of a decrease in the cell–cell
adhesion induced by the tumour growth factor.
(iii) Cell–cell adhesion = cell–matrix adhesion. To ensure the same values for the
adhesive strength functions (2.6) when there is no TGF-β in the system, we
choose s∗i = s
∗ = c∗i = 0.8 and ai = d = ei = 0.5, i = 1, 2. In Figs. 4(a)
and 4(b), we see that some cells in the two cancer sub-populations move quickly
to the left and the right, reaching the boundaries, while other cells (both u1 and
u2) stay in the middle of the domain and create a chaotic-like pattern (even if
u1 is slowly eliminated for t > 50). If we now add TGF-β to the system, we see
Fig. 4. (Colour online) Patterns exhibited by model (4.6) showing the eﬀect of TGF-β on cancer
cell density for the same cell–cell and cell–matrix adhesion, i.e. s∗i = s
∗ = c∗i = 0.8 and ai = d =
ei = 0.5, i = 1, 2. The rest of model parameters are given in Table A.2. (a), (b) Density of u1 and
u2 populations in the absence of TGF-β. The inset in panel (b) shows the long-term dynamics of
u2(t, x) (for t ≤ 1000); (a′), (b′) Density of u1 and u2 populations in the presence of TGF-β.
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in Figs. 4(a′) and 4(b′) that both u1 and u2 populations move slower towards
the edges of the domain. In contrast to the u2 population in the absence of
TGF-β, which exhibits a chaotic clumping and splitting behaviour (panel (b)),
the u2 population in the presence of TGF-β exhibits travelling-wave dynamics
(panel (b′)). This is diﬀerent from the dynamics observed in Fig. 3(b′) where
the u2 cells move in a travelling-wave manner up to t = 200, after which they
quickly move towards the boundaries.
Reducing now the magnitudes of cellular adhesion forces to s∗i = s
∗= c∗i =
0.1, i = 1, 2, we see in Fig. 5 that irrespective of the absence/presence of
TGF-β, population u1 forms a stationary aggregation that eventually vanishes
for large times, while population u2 exhibits a travelling wave. This behaviour
might be explained by the combined eﬀect of high mutation rate and clonal
competition (see the logistic growth terms in (2.2)), since adhesive forces are
very small and lead to the spread of population u2. In contrast to the dynamics
in Figs. 3(b) and 3(b′), and 4(b) and 4(b′), where the u2 cells seem to travel
slower towards the boundaries in the presence of TGF-β (compared to the
absence of TGF-β), in Fig. 5 the u2 cells travel faster to the boundaries in
the presence of TGF-β. We deduce from here that the spread of tumour cells
depends both on the magnitude of adhesive forces as well as on the presence
of TGF-β molecules.
Fig. 5. (Colour online) Patterns exhibited by model (4.6) showing the eﬀect of TGF-β on cancer
cell density for the same cell–cell and cell–matrix adhesion, i.e. s∗i = s
∗ = c∗i = 0.1 and ai = d =
ei = 0.5, i = 1, 2. The rest of model parameters are given in Table A.2. (a), (b) Density of u1
and u2 populations in the absence of TGF-β; (a′), (b′) Density of u1 and u2 populations in the
presence of TGF-β.
M
at
h.
 M
od
el
s M
et
ho
ds
 A
pp
l. 
Sc
i. 
D
ow
nl
oa
de
d 
fro
m
 w
w
w
.w
or
ld
sc
ie
nt
ifi
c.
co
m
by
 1
34
.3
6.
13
9.
10
7 
on
 0
7/
25
/1
7.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
2nd Reading
July 5, 2017 12:43 WSPC/103-M3AS 1750035
The multiple roles of TGF-β pathway on tumour 27
We note here that we also investigated numerically the case when TGF-
β is present, but does not inﬂuence cell proliferation or cell adhesion (i.e. for
θβ , p3, µ1, µ2 = 0, and cb = abi = db = ebi = 0, i = 1, 2). The patterns (not
shown here) that we obtained were similar to those presented in Figs. 2(a) and
2(b), 3(a) and 3(b), 4(a) and 4(b), 5(a) and 5(b). This suggests that the eﬀect of
TGF-β on the cancer cell density is greater than the eﬀect on the ECM and on the
integrins density.
5. Conclusion and Discussion
In this paper, we introduced a model of integro-diﬀerential equations describing the
dynamics of early stage and late stage cancer cell populations, under the eﬀect of
TGF-β signalling. The model was then used to investigate the role of TGF-β on
cellular adhesion and proliferation.
We ﬁrst proved the global existence of bounded solutions to our non-local model
by taking a vanishing viscosity approach and approximating our model with a non-
local parabolic PDE. The proof used the Banach contraction mapping theorem, the
Mo¨ser–Alikakos method and the vanishing viscosity method.
We then investigated numerically the solution of this non-local model, paying
particular attention to the eﬀect of TGF-β on cell–cell and cell–matrix interactions.
We showed that: (i) In the absence of TGF-β, the magnitudes of cell–cell and cell–
matrix interactions inﬂuenced the formation of cancer cell aggregation at speciﬁc
position in space (see Figs. 2(b), 3(b) and 4(b)); (ii) The consideration of TGF-β
leads to the spread of mutated (i.e. u2) cancer cells over the whole domain mainly
in a travelling-wave manner (with no cell aggregations; see Figs. 3(b′), 4(b′) and
5(b′)). We also emphasise that the speed at which cells spread depended on the
presence/absence of TGF-β and on the magnitudes of cell adhesion forces (see
Figs. 4(b) and 4(b′) versus Figs. 5(b) and 5(b′)).
While the numerical investigation of cancer spread uncovered an interesting
combined eﬀect of cell adhesion and presence/absence of TGF-β, in the future
we plan to investigate analytically the travelling waves and study the eﬀect of
parameters related to TGF-β and cell adhesion on the speed of these waves.
Appendix A. Summary of Model Variables and Parameters
Here we present two tables with the model variables and parameters. In Table A.1,
we list the model variables with their units. In Table A.2, we list the parameters
of our model and their corresponding units and non-dimensional values used in the
simulations.
Parameter estimation
• Attraction and repulsion ranges were chosen to be smaller or equal to sensing
radius, with the repulsion range to be smaller than the attraction range.25
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Table A.1. A list of model variables with their units. Since we
are in 1D, length and volume coincide and we express the vari-
ables in terms of domain length.
Variable Description Dimensional units
u1 Early stage cancer cell density cell/length
u2 Late stage cancer cell density cell/length
f ECM density mg/length
c Integrin density integrins/cell
b TGF-β concentration mg/length
Table A.2. A list of model parameters with their units and their non-dimensional values,
obtained from (4.4) and (4.5), which we used during numerical simulations.
Param. Description Dimensional units Non-dim. value (p˜) Reference
Du Diﬀusion coeﬃcient of u1 length
2/time 0.0001 11
Rs Sensing radius length 0.99 3 and 24
qa Magnitude of attraction length
2/cell 0.09 Estimated
qr Magnitude of repulsion length
2/cell 0.01 Estimated
sa Attraction range length 0.99 Estimated
sr Repulsion range length 0.25 Estimated
ma Width of attraction
kernel
length 0.99/8 Estimated
mr Width of repulsion kernel length 0.25/8 Estimated
r1 Growth rate of u1 1/time 0.1 50
r2 Growth rate of u2 1/time 0.2 50
M Mutation rate 1/time 0.05 14, 28 and 43
cb Coeﬀ. related to the
eﬀect of TGF-β on
cancer cell proliferation
Nondim. 20 Estimated
a1 Coeﬀ. related to the
number of integrins
necessary for max
self-adhesion between
u1
cell/integrins 0.7 Estimated
a2 Coeﬀ. related to the
number of integrins
necessary for max
self-adhesion between
u2
cell/integrins 0.3 Estimated
d Coeﬀ. related to the
number of integrins
necessary for max
cell–cell cross-adhesion
cell/integrins 0.5 Estimated
e1 Coeﬀ. related to the
number of integrins
necessary for max
cell–ECM adhesion for
u1
cell/integrins 1.8 Estimated
e2 Coeﬀ. related to the
number of integrins
necessary for max
cell–ECM adhesion for
u2
cell/integrins 2.5 Estimated
(Continued)
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Table A.2. (Continued)
Param. Description Dimensional units Non-dim. value (p˜) Reference
ab1 Coeﬀ. related to the
eﬀect of TGF-β on
self-adhesion between
u1 cells
length/mg 0.5 Estimated
ab2 Coeﬀ. related to the
eﬀect of TGF-β on
self-adhesion between
u2 cells
length/mg 0.3 Estimated
db Coeﬀ. related to the
eﬀect of TGF-β on
cell–cell cross-adhesion
length/mg 0.4 Estimated
eb1 Coeﬀ. related to the
eﬀect of TGF-β on
cell–ECM adhesion for
u1 cells
length/mg 0.8 Estimated
eb2 Coeﬀ. related to the
eﬀect of TGF-β on
cell–ECM adhesion for
u2 cells
length/mg 0.9 Estimated
s∗1 Magnitude of
self-adhesion forces of
u1
length/(time · cell) 0.1–2.4 Estimated
s∗2 Magnitude of
self-adhesion forces of
u2
length/(time · cell) 0.1–2 Estimated
s∗ Magnitude of
cross-adhesion forces
length/(time · cell) 0.1–2.1 Estimated
c∗1 Magnitude of cell–ECM
forces of u1
length/(time · cell) 0.1–1.9 Estimated
c∗2 Magnitude of cell–ECM
forces of u2
length/(time · cell) 0.1–2.5 Estimated
α Rate of ECM
degradation by u1
length/(time · cell) 1 59
β Rate of ECM
degradation by u2
length/(time · cell) 2 59
θβ Binding rate of TGF-β
to ECM components
length/(time ·mg) 0.77 Estimated
δ ECM remodelling rate 1/time 0.25 11
p1 Production rate of c by
u1
integrins/(time · cell) 0.05 Estimated
p2 Production rate of c by
u2
integrins/(time · cell) 0.1 Estimated
p3 Up-regulation rate of c
by b
length/(time ·mg) 0.2 Estimated
q Decay rate of c 1/time 0.3 39
Db Diﬀusion coeﬃcient of
TGF-β
length2/time 0.007 64
µ1 Production rate of b by
u1
mg/(time · cell) 0.05 36 and 69
µ2 Production rate of b by
u2
mg/(time · cell) 0.05 36 and 69
qb Decay rate of b 1/time 0.05 39
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• Various experimental studies15,50 have shown that doubling times for tumour
cells range from 1−10 days. This corresponds to growth rates between
(ln(2)/10, ln(2)/1) = (0.07, 0.7). In this study, we assume that r˜1 = 0.1 and
r˜2 = 0.2.
• Experimental studies14,28,43 have shown that the mutation rate ranges between
M = 10−3/day and M = 0.1/day. Thus the non-dimensional value of the muta-
tion rate is in the range between M˜ = 0.001 and M˜ = 0.1 (for highly aggressive
tumours). In this study, we choose M˜ = 0.05.
• The parameters ai, d, ei, s∗i , s∗, c∗i , i = 1, 2, were based on the range of the adhe-
sion strength parameters used in Ref. 3.
• Experimental studies35 have shown greater production of integrins for mutated
cancer cells. Thus, we choose p1 < p2.
• Experimental studies16,17,39,40 have shown that the half-lifes of the inte-
grins range from 0.04−4 days. This corresponds to a decay rate between
(ln(2)/4, ln(2)/0.04) = (0.17, 17.3). In this study, we assume that q˜ = 0.3.
• The remodelling rate was chosen to be greater than cell proliferation rate, as
considered also in Ref. 11.
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